<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3628">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03059680</url>
  </required_header>
  <id_info>
    <org_study_id>MSH 11-0259-A</org_study_id>
    <nct_id>NCT03059680</nct_id>
  </id_info>
  <brief_title>Effects of Implementing a High Potassium Diet in Heart Failure Patients</brief_title>
  <official_title>Safety and Physiologic Effects of Implementing a High Potassium Diet in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samuel Lunenfeld Research Institute, Mount Sinai Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and physiologic effects of increasing dietary potassium
      intake in individuals with heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum potassium concentration</measure>
    <time_frame>10 days and 3 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Flow Mediated Dilatation</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>24 hour urinary potassium excretion</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3 day dietary food record</measure>
    <time_frame>10 days and 3 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>High potassium diet group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Individuals in this arm were asked to increase dietary potassium intake over a 4 week period. This was achieved through an increase in consumption of fruits and vegetables.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual diet group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Individuals in this group were asked to continue habitual dietary intake</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High potassium diet</intervention_name>
    <description>An increase in consumption of high potassium fruits and vegetables</description>
    <arm_group_label>High potassium diet group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients classified as having HF, both systolic and diastolic.

          -  New York Heart Association class II-III symptoms.

          -  Treatment with an beta blocker, ACE inhibitor, or angiotensin receptor blocker
             without any adjustment over the previous month

          -  Intake at baseline of â‰¤ 3 servings of fruits and vegetables per day. Servings defined
             by Health Canada's food guide.

        Exclusion Criteria:

          -  Patients with an episode of decompensated heart failure, acute coronary syndrome, or
             revascularization within the previous 3 months of study inclusion.

          -  Patients receiving insulin therapy

          -  Glomerular filtration rate &lt; 40mL/min/1.73 m2

          -  Pregnancy and lactation (women of childbearing potential will be included but will
             have to have a negative pregnancy test prior to inclusion).

          -  Inability to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 16, 2017</lastchanged_date>
  <firstreceived_date>February 16, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Potassium</keyword>
  <keyword>Nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
